994
Views
0
CrossRef citations to date
0
Altmetric
Licensed Vaccines

Number of tetanus toxoid injections before birth and associated factors among pregnant women in low and middle income countries: Negative binomial poisson regression

, , , , , , , , , , , & show all
Article: 2352905 | Received 13 Feb 2024, Accepted 04 May 2024, Published online: 21 May 2024

References

  • World Health Organization (WHO) global health achievements 2023.
  • WHO. Protecting all against tetanus: guide to sustaining maternal and neonatal tetanus elimination (‎MNTE)‎ and broadening tetanus protection for all populations; 2019.
  • Farnworth E, Roberts A, Rangaraj A, Minhas U, Holloway S, Harding K. Tetanus in patients with chronic wounds–are we aware? Int Wound J. 2012;9(1):93–11. doi:10.1111/j.1742-481X.2011.00850.x.
  • Organization WH. Surveillance standards for vaccine-preventable diseases; 2018.
  • Organization WH. Weekly epidemiological record: tetanus vaccines. Switzerland; 2017.
  • Raya BA, Srugo I, Kessel A, Peterman M, Bader D, Peri R, Ashtamker N, Gonen R, Bamberger E. The induction of breast milk pertussis specific antibodies following gestational tetanus–diphtheria–acellular pertussis vaccination. Vaccine. 2014;32(43):5632–7. doi:10.1016/j.vaccine.2014.08.006.
  • Halperin B, Morris A, Mackinnon-Cameron D, Mutch J, Langley J, McNeil S, MacDougall D, Halperin SA. Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women. Clin Infect Dis. 2011;53(9):885–92. doi:10.1093/cid/cir538.
  • Saso A, Kampmann B. Maternal immunization: nature meets nurture. Front Microbiol. 2020;11:531598. doi:10.3389/fmicb.2020.01499.
  • Atyeo C, Alter G. The multifaceted roles of breast milk antibodies. Cell. 2021;184(6):1486–99. doi:10.1016/j.cell.2021.02.031.
  • Erdogan RR, Dolatshahi S. Quantitative mechanistic model reveals key determinants of placental IgG transfer and informs prenatal immunization strategies. bioRxiv 2023;19(11):e1011109.
  • Albrecht M, Arck PC. Vertically transferred immunity in neonates: mothers, mechanisms and mediators. Front Immunol. 2020;11:526432. doi:10.3389/fimmu.2020.00555.
  • Coakley CM, Staszewski V, Herborn KA, Cunningham EJ. Factors affecting the levels of protection transferred from mother to offspring following immune challenge. Front Zool. 2014;11(1):1–11. doi:10.1186/1742-9994-11-46.
  • Stelzer IA, Urbschat C, Schepanski S, Thiele K, Triviai I, Wieczorek A, Alawi M, Ohnezeit D, Kottlau J, Huang J. et al. Vertically transferred maternal immune cells promote neonatal immunity against early life infections. Nat Commun. 2021;12(1):4706. doi:10.1038/s41467-021-24719-z.
  • Yusuf N, Steinglass R, Gasse F, Raza A, Ahmed B, Blanc DC, Yakubu A, Gregory C, Tohme RA. Sustaining Maternal and Neonatal Tetanus Elimination (MNTE) in countries that have been validated for elimination–progress and challenges. BMC Public Health. 2022;22(1):1–12. doi:10.1186/s12889-022-13110-2.
  • Njuguna HN, Yusuf N, Raza AA, Ahmed B, Tohme RA. Progress toward maternal and neonatal tetanus elimination—worldwide, 2000–2018. MMWR Morb Mortal Wkly Rep. 2020;69(17):515. doi:10.15585/mmwr.mm6917a2.
  • Moniz MH, Beigi RH. Maternal immunization: clinical experiences, challenges, and opportunities in vaccine acceptance. Hum Vaccines Immunother. 2014;10(9):2562–70. doi:10.4161/21645515.2014.970901.
  • World Health Organization. (WHO)-maternal and neonatal tetanus elimination (Mnte)/the strategies. 2019. https://www.who.int/initiatives/maternal-and-neonatal-tetanus-elimination-%28mnte%29/the-strategies.
  • WHO U. World Bank. State of the world’s vaccines and immunization. Geneva: World Health Organization; 2009. 2017.
  • Akwataghibe NN, Ogunsola EA, Broerse JE, Popoola OA, Agbo AI, Dieleman MA. Exploring factors influencing immunization utilization in Nigeria—a mixed methods study. Front Public Health. 2019;7:392. doi:10.3389/fpubh.2019.00392.
  • Mengesha MB, Weldegeorges DA, Assefa NE, Gebremeskel SG, Hidru HD, Teame H, Hailesilassie Y. Tetanus toxoid immunization status and associated factors among mothers in Hawzen, eastern zone of Tigray, Ethiopia, 2019. Open Public Health J. 2020;13(1):281–8. doi:10.2174/1874944502013010281.
  • Khan REA, Raza MA. Maternal health-care in India: the case of tetanus toxoid vaccination. Asian Dev Policy Rev. 2013;1(1):1–14. doi:10.18488/journal.107.2013.11.1.14.
  • Organization WH. Weekly Epidemiological Record, 1928, vol. 03, 126 [full issue]. Weekly Epidemiological Record = relevé épidémiologique hebdomadaire. Organi WH. Weekly Epidem Rec. 1928;3(126):1–5.
  • Singh A, Pallikadavath S, Ogollah R, Stones W, Crowcroft NS. Maternal tetanus toxoid vaccination and neonatal mortality in rural north India. PLOS ONE. 2012;7(11):e48891. doi:10.1371/journal.pone.0048891.
  • Naeem M, Khan M-U-I, Abbas SH, Adil M, Khan A, Naz SM, Khan MU. Coverage and factors associated with tetanus toxoid vaccination among married women of reproductive age: a cross sectional study in Peshawar. J Ayub Med Coll Abbottabad. 2010;22(3):136–40.
  • Hashmi FK, Islam M, Khan TA, Tipu MK. Vaccination coverage of mothers during pregnancy with tetanus toxoid and infants after birth. Pakistan J Pharm. 2011;24:1–3.
  • Haile ZT, Chertok IRA, Teweldeberhan AK. Determinants of utilization of sufficient tetanus toxoid immunization during pregnancy: evidence from the Kenya demographic and health survey, 2008–2009. J Community Health. 2013;38(3):492–9. doi:10.1007/s10900-012-9638-9.
  • Masuno K, Xaysomphoo D, Phengsavanh A, Douangmala S, Kuroiwa C. Scaling up interventions to eliminate neonatal tetanus: factors associated with the coverage of tetanus toxoid and clean deliveries among women in Vientiane, Lao PDR. Vaccine. 2009;27(32):4284–8. doi:10.1016/j.vaccine.2009.05.024.
  • Tesfahun F, Worku W, Mazengiya F, Kifle M. Knowledge, perception and utilization of postnatal care of mothers in Gondar Zuria District, Ethiopia: a cross-sectional study. Matern Child Health J. 2014;18(10):2341–51. doi:10.1007/s10995-014-1474-3.
  • Abdella A. Maternal mortality trend in Ethiopia. Ethiop J Health Dev. 2010;24(1). doi:10.4314/ejhd.v24i1.62953.
  • Messeret ES, Masresha B, Yakubu A, Daniel F, R M, Nshimirimana D, Okeibunor J, Akanmori B. Maternal and neonatal tetanus elimination (MNTE) in the WHO African region. J Immunological Sci. 2018;2(SI1):103. doi:10.29245/2578-3009/2018/si.1115.
  • Giles M, Mantel C, Muñoz F, Moran A, Roos N, Yusuf N, Diaz T, Ahun M, Nic Lochlainn LM, Wootton E. et al. Vaccine implementation factors affecting maternal tetanus immunization in low- and middle-income countries: results of the maternal immunization and Antenatal Care Situational Analysis (MIACSA) project. Vaccine. 2020;38(33):5268–77. doi:10.1016/j.vaccine.2020.05.084.
  • Hamadeh N, Van Rompaey C, Metreau E. World Bank Group country classifications by income level for FY24 (July 1, 2023–June 30, 2024). New Hampshire, United States: The World Bank Group; 2023.
  • World Bank Country and Lending Groups. 2023. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups.
  • Olaniyan A, Isiguzo C, Hawk M. The socioecological model as a framework for exploring factors influencing childhood immunization uptake in Lagos state, Nigeria. BMC Public Health. 2021;21(1):867. doi:10.1186/s12889-021-10922-6.
  • Muluken Dubale Mamoro MDM, Lolemo Kelbiso Hanfore LKH. Tetanus toxoid immunization status and associated factors among mothers in Damboya Woreda, Kembata Tembaro Zone. Ethiopia: SNNP; 2018.
  • Gebremedhin TS, Welay FT, Mengesha MB, Assefa NE, Werid WM. Tetanus toxoid vaccination uptake and associated factors among mothers who gave birth in the last 12 months in Errer District, Somali regional state, eastern Ethiopia. Biomed Res Int. 2020;2020:1–8. doi:10.1155/2020/4023031.
  • Awosan K, Hassan M. Perception and utilization of tetanus toxoid immunization among pregnant women attending a tertiary centre in North-West Nigeria. J Drug Delivery Ther. 2018;8(6):119–24. doi:10.22270/jddt.v8i6.2032.
  • Yaya S, Kota K, Buh A, Bishwajit G. Prevalence and predictors of taking tetanus toxoid vaccine in pregnancy: a cross-sectional study of 8,722 women in Sierra Leone. BMC Public Health. 2020;20(1):1–9. doi:10.1186/s12889-020-08985-y.
  • Yaya S, Kota K, Buh A, Bishwajit G. Antenatal visits are positively associated with uptake of tetanus toxoid and intermittent preventive treatment in pregnancy in Ivory Coast. BMC Public Health. 2019;19(1):1–12. doi:10.1186/s12889-019-7847-1.
  • Iqbal S, Ali I, Ekmekcioglu C, Kundi M. Increasing frequency of antenatal care visits may improve tetanus toxoid vaccination coverage in pregnant women in Pakistan. Hum Vaccines Immunother. 2020;16(7):1529–32. doi:10.1080/21645515.2019.1705693.
  • Gabriel-Job N, Ide LY. Tetanus toxoid status and determinants of uptake among women in Etche local government area, Rivers State, Nigeria: a community based study. AJMAH. 2020;17(4):1–7. doi:10.9734/ajmah/2019/v17i430171.
  • McCullagh P. Generalized linear models. New York: Routledge; 2019.
  • Maral I, Baykan Z, Aksakal F, Kayikcioglu F, Bumin M. Tetanus immunization in pregnant women: evaluation of maternal tetanus vaccination status and factors affecting rate of vaccination coverage. Public Health. 2001;115(5):359–64. doi:10.1016/S0033-3506(01)00476-0.
  • Faria APV, da Silva TPR, Vieira EWR, Lachtim SAF, Rezende EM, Matozinhos FP. Factors associated with tetanus vaccination in pregnant women living in Minas Gerais State, Brazil: a cross-sectional study. Public Health Pract (Oxf). 2021;2:100203. doi:10.1016/j.puhip.2021.100203.
  • Kilich E, Dada S, Francis MR, Tazare J, Chico RM, Paterson P, Larson HJ. Factors that influence vaccination decision-making among pregnant women: a systematic review and meta-analysis. PLOS ONE. 2020;15(7):e0234827. doi:10.1371/journal.pone.0234827.
  • Gianfredi V, Berti A, Stefanizzi P, D’Amico M, De Lorenzo V, Moscara L, Di Lorenzo A, Venerito V, Castaldi S. COVID-19 vaccine knowledge, attitude, acceptance and hesitancy among pregnancy and breastfeeding: systematic review of hospital-based studies. Nato Adv Sci Inst Se. 2023;11(11):1697. doi:10.3390/vaccines11111697.
  • Hsu AL, Johnson T, Phillips L, Nelson TB. editors. Sources of vaccine hesitancy: pregnancy, infertility, minority concerns, and general skepticism. In Open forum infectious diseases. New York: Oxford University Press US; 2022.
  • Fenta SM, Fenta HM. Magnitude of tetanus toxoid immunization and associated factors among pregnant women in Ethiopia. Open Public Health J. 2023;16(1). doi:10.2174/18749445-v16-e230111-2022-161.
  • Dubale Mamoro M, Kelbiso Hanfore L. Tetanus toxoid immunization status and associated factors among mothers in Damboya Woreda, Kembata Tembaro zone, SNNP, Ethiopia. J Nutr Metab. 2018;2018:1–9. doi:10.1155/2018/2839579.
  • Anatea MD, Mekonnen TH, Dachew BA. Determinants and perceptions of the utilization of tetanus toxoid immunization among reproductive-age women in Dukem Town, Eastern Ethiopia: a community-based cross-sectional study. BMC Int Health Hum Rights. 2018;18(1):1–0. doi:10.1186/s12914-018-0168-0.
  • Hassan AM, Shoman AE, Abo-Elezz NF, Amer MM. Tetanus vaccination status and its associated factors among women attending a primary healthcare center in Cairo Governorate, Egypt. J Egypt Public Health Assoc. 2016;91(3):127–34. doi:10.1097/01.EPX.0000491267.30015.2a.
  • Gabriel-Job N, Yaguo E, Ide L. Tetanus toxoid status and determinants of uptake among women in Etche local government area, Rivers State, Nigeria: a community based study. Asian J Med Health. 2020;17(4):1–7. doi:10.9734/ajmah/2019/v17i430171.
  • Amin MB, Roy N, Meem AE, Hossain E, Aktarujjaman M, Antonello VS. Trends and determinants of taking tetanus toxoid vaccine among women during last pregnancy in Bangladesh: country representative survey from 2006–2019. PLOS ONE. 2022;17(10):e0276417. doi:10.1371/journal.pone.0276417.
  • Liyew AM, Ayalew HG. Individual and community-level determinants of poor tetanus toxoid immunization among pregnant women in Ethiopia using data from 2016 Ethiopian demographic and health survey; multilevel analysis. Arch Belg. 2021;79(1):1–0. doi:10.1186/s13690-021-00622-3.
  • Faria A, da Silva T, Duarte C, Mendes L, Santos F, Matozinhos F. Tetanus vaccination in pregnant women: a systematic review and meta-analysis of the global literature. Public Health. 2021;196:43–51. doi:10.1016/j.puhe.2021.04.019.
  • Wilson RJ, Paterson P, Jarrett C, Larson HJ. Understanding factors influencing vaccination acceptance during pregnancy globally: a literature review. Vaccine. 2015;33(47):6420–9. doi:10.1016/j.vaccine.2015.08.046.
  • Owusu-Boateng I, Anto F. Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine–pyrimethamine five dose policy in Ghana. Malar J. 2017;16(1):1–9. doi:10.1186/s12936-017-1969-7.
  • Hill J, Kayentao K, Touré M, Diarwara S, Bruce J, Smedley J, Doumbo OK, ter Kuile FO, Webster J. Effectiveness of antenatal clinics to deliver intermittent preventive treatment and insecticide treated nets for the control of malaria in pregnancy in Mali: a household survey. PLOS ONE. 2014;9(3):e92102. doi:10.1371/journal.pone.0092102.
  • Azizi SC, Chongwe G, Chipukuma H, Jacobs C, Zgambo J, Michelo C. Uptake of intermittent preventive treatment for malaria during pregnancy with sulphadoxine-pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study. BMC Pregnancy Childbirth. 2018;18(1):1–13. doi:10.1186/s12884-018-1744-y.
  • İnakçı Hİ, Şimsek Z, Koruk İ, Koruk ST. Coverage of tetanus vaccine after national tetanus vaccination campaign and basic determinants in Şanliurfa. Turk Silahli Kuvvetleri Koruyucu Hekim Bul. 2009;8(6).
  • Barrow A, Barrow S, Jobe A. Differentials in prevalence and correlates on uptake of tetanus toxoid and intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy: a community-based cross-sectional study in the Gambia. SAGE Open Med. 2022;10:20503121211065908. doi:10.1177/20503121211065908.
  • Nigussie J, Girma B, Molla A, Mareg M. Tetanus toxoid vaccination coverage and associated factors among childbearing women in Ethiopia: a systematic review and meta-analysis. Biomed Res Int. 2021;2021:1–0. doi:10.1155/2021/5529315.
  • Pathirana J, Nkambule J, Black S. Determinants of maternal immunization in developing countries. Vaccine. 2015;33(26):2971–7. doi:10.1016/j.vaccine.2015.04.070.
  • van der Hoeven M, Kruger A, Greeff M. Differences in health care seeking behaviour between rural and urban communities in South Africa. Int J Equity Health. 2012;11(1):1–9. doi:10.1186/1475-9276-11-31.
  • Mehanna A, Ali MH, Kharboush I. Knowledge and health beliefs of reproductive-age women in Alexandria about tetanus toxoid immunization. J Egypt Public Health Assoc. 2020;95(1):1–11. doi:10.1186/s42506-020-00049-8.
  • Mohamed SOO, Ahmed EM. Prevalence and determinants of antenatal tetanus vaccination in Sudan: a cross-sectional analysis of the multiple indicator cluster survey. Trop Med Health. 2022;50(1):1–6. doi:10.1186/s41182-022-00398-4.
  • Mukungwa T. Factors associated with full immunization coverage amongst children aged 12–23 months in Zimbabwe. African Population Studies. 2015;29(2). doi:10.11564/29-2-745.
  • Hasnain S, Sheikh N. Causes of low tetanus toxoid vaccination coverage in pregnant women in Lahore district, Pakistan. EMHJ-Eastern Mediterranean Health Journal. 2007;13(5):1142–52. doi:10.26719/2007.13.5.1142.
  • Hulsey TM, Laken M, Miller V, Ager J. The influence of attitudes about unintended pregnancy on use of prenatal and postpartum care. J Perinatol. 2000;20(8):513–9. doi:10.1038/sj.jp.7200455.
  • Kachimba J. Factors contributing to low tetanus toxoid immunization coverage among women of child bearing age in Luanshya district; 2014.
  • Asia Hemed K, Sweetness Naftal L, Perry M C, Zuhura L, Nateiya M Y, Neema Allen NA, Irene H, Blandina Theophil M, Agnes Cyril M. A qualitative study on perspectives of pregnant and postnatal mothers on accessing tetanus Toxoid vaccine in Hai District Kilimanjaro region Tanzania. J Gynecol Res Obstet. 2021;7(3):042–9. doi:10.17352/jgro.000104.
  • Usman HR, Kristensen S, Rahbar MH, Vermund SH, Habib F, Chamot E. Determinants of third dose of diphtheria–tetanus–pertussis (DTP) completion among children who received DTP1 at rural immunization centres in Pakistan: a cohort study. Tropical Medicine & International Health: TM & IH. 2010;15(1):140. doi:10.1111/j.1365-3156.2009.02432.x.
  • P-J L, O’Halloran A, Williams WW. Impact of health insurance status on vaccination coverage among adult populations. Am J Prev Med. 2015;48(6):647–61. doi:10.1016/j.amepre.2014.12.008.